This is the authors' abstract. We don't add key points for this paper.
This review presents the current knowledge on diagnosis, therapy of relapses of multiple Sclerosis (MS) and disease-modifying therapy (DMT) in MS. Algorithms of diagnosis and therapy of MS are presented. Special attention is paid to the analysis of efficacy, tolerability and safety of DMT in MS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Е. И. Гусев (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: